The drug is currently approved for a relatively narrow group of patients with extremely high levels of triglycerides.
FDA-written drug labels guide physician prescribing and often determine which uses are paid for by insurers.
Patients in the trial had high triglycerides and other risk factors for heart problems, such as diabetes.failed to show a positive impact on heart health. Millions of Americans take over-the-counter fish oil supplements for their presumed health benefits. These oils, also called If approved, Vascepa would be the first fat-lowering drug endorsed by the FDA to reduce heart problems.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Trump administration wavers on ban of flavored e-cigarettes, FDA official says 'no final answer' nowA top FDA official wavered on whether the Trump administration will follow through with its ban of flavored e-cigarettes, telling lawmakers there is 'no final answer' right now.
Baca lebih lajut »
Most Americans Wrongly Think CBD Is Regulated By FDA, Survey FindsAccording to data from the Grocery Manufacturers Association, 76% of Americans who know about CBD believe commercial products are federally regulated, which they aren't
Baca lebih lajut »
FDA issues warning to Dollar Tree about selling 'potentially unsafe drugs'The US Food and Drug Administration has issued a warning letter to Dollar Tree for receiving over-the-counter drugs produced by foreign manufacturers that have been found to be adulterated, including acne treatment pads and Assured brand drugs.
Baca lebih lajut »
Dollar Tree accused of unsafe drugs imports despite FDA warning - Business InsiderThe FDA issued a warning letter to Dollar Tree this month alleging it continued to receive potentially unsafe over-the-counter drugs from China.
Baca lebih lajut »
FDA flags Dollar Tree for selling over-the-counter drugs made by companies with 'pattern of serious violations'Dollar Tree sold over-the-counter drugs produced by foreign companies with 'a pattern of serious violations' of federal law on good manufacturing practices, the Food and Drug Administration alleges in a warning letter sent to the company Thursday.
Baca lebih lajut »